title: Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
authors.affiliation: Department of Surgery, University of Texas Medical School at Houston 77030.
authors.forename: M
authors.initials: M
authors.lastname: Wang
authors.forename: S M
authors.initials: SM
authors.lastname: Stepkowski
authors.forename: B D
authors.initials: BD
authors.lastname: Kahan
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006085:Graft Survival / Q000276:immunology; D006086:Graft vs Host Disease / Q000517:prevention & control*; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*; D011798:Quinaldines
chemical_list: D000911:Antibodies, Monoclonal; D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; D016693:Receptors, Antigen, T-Cell, alpha-beta; C046943:brequinar; D011798:Quinaldines